Chemoresistance of Plasmodium falciparum and Plasmodium vivax parasites in Brazil: Consequences on disease morbidity and control

Memorias do Instituto Oswaldo Cruz

Volumn 106, Issue SUPPL. 1, 2011, Pages 159-166

  Gama, Bianca Ervatti ^a   Lacerda, Marcus Vinicius Guimarães ^b   Daniel Ribeiro, Cláudio Tadeu ^a   Ferreira da Cruz, Maria de Fátima ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b FUNDAÇÃO DE MEDICINA TROPICAL DR HEITOR VIEIRA DOURADO   (Brazil)

Author keywords

Brazil; Chemoresistance; Malaria; Plasmodium falciparum; Plasmodium vivax

Indexed keywords

ANTIMALARIAL AGENT;

BRAZIL; DRUG EFFECT; DRUG RESISTANCE; GENETICS; HUMAN; MALARIA FALCIPARUM; PARASITOLOGY; PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; PLASMODIUM VIVAX MALARIA; REVIEW;

ANTIMALARIALS; BRAZIL; DRUG RESISTANCE; HUMANS; MALARIA, FALCIPARUM; MALARIA, VIVAX; PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX;

PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX;

EID: 80051731809     PISSN: 00740276     EISSN: 16788060     Source Type: Journal    
DOI: 10.1590/S0074-02762011000900020     Document Type: Review

References (100)

1. Alecrim M, Alecrim W, Macêdo V 1999a. Plasmodium vivax resistance to chloroquine (R2) and mefloquine (R3) in Brazilian Amazon Region. Rev Soc Bras Med Trop 32: 67-68.
2. Alecrim M, Alecrim W, Macêdo V, Korves C, Roberts D, Li J, Sullivan M, McCutchan T 1999b. Description of a possible clonal expansion of Plasmodium vivax in Manaus-Amazonas-Brazil. Rev Soc Bras Med Trop 32: 303-305.
3. Alecrim MG, Alecrim WD, de Albuquerque BC, Dourado HV, Wanssa MoC 1982a. Resistance of Plasmodium falciparum in the Brazilian Amazonas to the combination of sulfadoxine and pyrimethamine. Rev Inst Med Trop Sao Paulo 24: 44-47.
4. Alecrim MG, Lacerda MV, Mourao MP, Alecrim WD, Padilha A, Cardoso BS, Boulos M 2006. Successful treatment of Plasmodium falciparum malaria with a six-dose regimen of artemether-lumefantrine versus quinine-doxycycline in the western Amazon region of Brazil. Am J Trop Med Hyg 74: 20-25.
5. Alecrim MGC 1981. Estudo da resistência do P. falciparum às drogas antimaláricas in vivo e in vitro na Amazônia, MSc Thesis, Universidade de Brasília, Brasília, 116 pp.
6. Alecrim WD, Dourado H, Alecrim M das G, Passos LF, Wanssa E, Albuquerque B 1982b. In vivo resistance of Plasmodium falciparum to the combination of sulfadoxine and pyrimethamine, at RIII level, in Amazonas, Brazil. Rev Inst Med Trop Sao Paulo 24: 52-53.
7. Alexandre MA, Ferreira CO, Siqueira AM, Magalhaes BL, Mourao MPG, Lacerda MVG, Alecrim MGC 2010. Severe Plasmodium vivax malaria, Brazilian Amazon. Emerg Infect Dis 16: 1611-1614.
8. Almeida Netto J, Oliveira G, Sampaio J 1972. Resistência do Plasmodium falciparum à associação sulfamídicos-antifolínicos na região Centro-Oeste do Brasil; dados referentes ao estudo de 104 casos. Rev Pat Trop 1: 385-393.
9. Andrade J, Andrade A, Araujo E, Oliveira R, Silva S, Martelli C, Zicker F 1992. A randomized clinical trial with high dose of chloroquine for treatment of Plasmodium falciparum malaria in Brazil. Rev Inst Med Trop Sao Paulo 34: 467-473.
10. Bacon DJ, McCollum AM, Griffing SM, Salas C, Soberon V, Santolalla M, Haley R, Tsukayama P, Lucas C, Escalante AA, Udhayakumar V 2009. Dynamics of malaria drug resistance patterns in the Amazon basin region following changes in Peruvian national treatment policy for uncomplicated malaria. Antimicrob Agents Chemother 53: 2042-2051.
11. Baird JK 2004. Chloroquine resistance in Plasmodium vivax. Antimicrob Agents Chemother 48: 4075-4083.
12. Baird JK 2009. Resistance to therapies for infection by Plasmodium vivax. Clin Microbiol Rev 22: 508-534.
13. Baird JK, Rieckmann KH 2003. Can primaquine therapy for vivax malaria be improved? Trends Parasitol 19: 115-120.
14. Boulos M, Amato Neto V, Dutra AP, Di Santi SM, Shiroma M 1991. Frequency of malaria relapse due to Plasmodium vivax in a non-endemic region (São Paulo, Brazil). Rev Inst Med Trop Sao Paulo 33: 143-146.
15. Boulos M, Di Santi SM, Barata LCB, Segurado AAC, Dutra AP, Neves VLF 1986. Some aspects of treatment, prophylaxis and chemoresistance of Plasmodium falciparum malaria. Mem Inst Oswaldo Cruz 81 (Suppl. II): 255-257.
16. Box ED, Box QT, Young MD 1963. Chloroquine-resistant Plasmodium falciparum from Porto Velho, Brazil. Am J Trop Med Hyg 12: 300-304.
17. Bray PG, Martin RE, Tilley L, Ward SA, Kirk K, Fidock DA 2005. Defining the role of pfcrt in Plasmodium falciparum chloroquine resistance. Mol Microbiol 56: 323-333.
18. Brega S, Meslin B, de Monbrison F, Severini C, Gradoni L, Udomsangpetch R, Sutanto I, Peyron F, Picot S 2005. Identification of the Plasmodium vivax mdr-like gene (pvmdr1) and analysis of single-nucleotide polymorphisms among isolates from different areas of endemicity. J Infect Dis 191: 272-277.
19. Brooks D, Wang P, Read M, Watkins W, Sims P, Hyde J 1994. Sequence variation of the hydroxymethyldihydropterin pyrophosphokinase: dihydropteroate synthase gene in lines of the human malaria parasite, Plasmodium falciparum, with differing resistance to sulfadoxine. Eur J Biochem 224: 397-405.
20. Calvosa VS, Adagu IS, Póvoa MM 2001. Plasmodium falciparum: emerging mefloquine resistance in vitro in Para state, North Brazil. Trans R Soc Trop Med Hyg 95: 330-331.
21. Carmargo L, de Oliveira S, Basano S, Garcia C 2009. Antimalarials and the fight against malaria in Brazil. Ther Clin Risk Manag 5: 311-317.
22. Cerutti C, Durlacher RR, de Alencar FE, Segurado AA, Pang LW 1999a. In vivo efficacy of mefloquine for the treatment of falciparum malaria in Brazil. J Infect Dis 180: 2077-2080.
23. Cerutti C Jr, Marques C, Alencar FEC, Durlacher RR, Alween A, Segurado AAC, Pang LW, Zalis MG 1999b. Antimalarial drug susceptibility testing of Plasmodium falciparum in Brazil using a radioisotope method. Mem Inst Oswaldo Cruz 94: 803-809.
24. Clyde D 1960. Cross resistance of malaria parasites. Trans R Soc Trop Med Hyg 54: 597-598.
25. Comer RD, Young MD, Porter JA, Gauld JR, Merritt W 1968. Chloroquine resistance in Plasmodium falciparum malaria on the Pacific coast of Colombia. Am J Trop Med Hyg 17: 795-799.
26. Couto AA, Calvosa VS, Santos MA, de Souza JM 1995. The evolution over time of the in-vitro resistance of Plasmodium falciparum to antimalarial drugs in 2 areas of the Brazilian Amazonia with distinct socioeconomic and geographic characteristics. Rev Soc Bras Med Trop 28: 357-365.
27. Cowman A, Morry M, Biggs B, Cross G, Foote S 1988. Amino acid changes linked to pyrimethamine resistance in the dihydrofolate reductase-thymidylate synthase gene of Plasmodium falciparum. Proc Natl Acad Sci USA 85: 9109-9113.
28. Daniel-Ribeiro C, Lacerda M, Oliveira-Ferreira J 2008. Paludisme dû à Plasmodium vivax en Amazonie brésilienne: quelques aspects de son épidémiologie, de ses manifestations cliniques et des réactions immunitaires naturallement acquises. Bull Soc Pathol Exot 101: 243-248.
29. de Pécoulas PE, Tahar R, Ouatas T, Mazabraud A, Basco LK 1998. Sequence variations in the Plasmodium vivax dihydrofolate reductase-thymidylate synthase gene and their relationship with pyrimethamine resistance. Mol Biochem Parasitol 92: 265-273.
30. Dondorp A, Nosten F, Yi P, Das D, Phyo A, Tarning J, Lwin K, Ariey F, Hanpithakpong W, Lee S, Ringwald P, Silamut K, Imwong M, Chotivanich K, Lim P, Herdman T, An S, Yeung S, Singhasivanon P, Day N, Lindegardh N, Socheat D, White N 2009. Artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med 361: 455-467.
31. Douglas NM, Anstey NM, Angus BJ, Nosten F, Price RN 2010. Artemisinin combination therapy for vivax malaria. Lancet Infect Dis 10: 405-416.
32. Duraisingh M, Cowman A 2005. Contribution of the pfmdr1 gene to antimalarial drug-resistance. Acta Trop 94: 181-190.
33. Eldin de Pécoulas P, Basco LK, Tahar R, Ouatas T, Mazabraud A 1998. Analysis of the Plasmodium vivax dihydrofolate reductase-thymidylate synthase gene sequence. Gene 211: 177-185.
34. Esterre P, Volney B, Meynard JB, Legrand E 2009. Importance of a regional observatory of malarial chemoresistance, an emerging public health problem in the Guyanas region. Bull Soc Pathol Exot 102: 179-184.
35. Ferraroni JJ, Speer CA, Hayes J, Suzuki M 1981. Prevalence of chloroquine-resistant falciparum malaria in the Brazilian Amazon. Am J Trop Med Hyg 30: 526-530.
36. Ferreira I, Martinelli A, Rodrigues L, do Carmo E, do Rosário V, Póvoa M, Cravo P 2008. Plasmodium falciparum from Pará state (Brazil) shows satisfactory in vitro response to artemisinin derivatives and absence of the S769N mutation in the SERCA-type PfATPase6. Trop Med Int Health 13: 199-207.
37. Fidock DA, Nomura T, Talley AK, Cooper RA, Dzekunov SM, Ferdig MT, Ursos LM, Sidhu AB, Naudé B, Deitsch KW, Su XZ, Wootton JC, Roepe PD, Wellems TE 2000. Mutations in the P. falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance. Mol Cell 6: 861-871.
38. Galappaththy GN, Omari AA, Tharyan P 2007. Primaquine for preventing relapses in people with Plasmodium vivax malaria. Cochrane Database Syst Ver 1: CD004389.
39. Gama BE, Almeida de Oliveira NK, Souza JM, Daniel-Ribeiro CT, Ferreira-da-Cruz MF 2009a. Characterisation of pvmdr1 and pvdhfr genes associated with chemoresistance in Brazilian Plasmodium vivax isolates. Mem Inst Oswaldo Cruz 104: 1009-1011.
40. Gama BE, Almeida de Oliveira NK, Zalis MG, Souza JM, Santos F, Daniel-Ribeiro CT, Ferreira-da-Cruz MF 2009b. Chloroquine and sulphadoxine-pyrimethamine sensitivity of Plasmodium falciparum parasites in a Brazilian endemic area. Malaria J 8: 156.
41. Gama BE, de Oliveira NKA, de Souza JM, Santos F, Carvalho LJM, Melo YFC, Rosenthal PJ, Daniel-Ribeiro CT, Ferreira-da-Cruz MF 2010. Brazilian Plasmodium falciparum isolates: investigation of candidate polymorphisms for artemisinin resistance before introduction of artemisinin-based combination therapy. Malaria J 9: 355.
42. Garavelli PL, Corti E 1992. Chloroquine resistance in Plasmodium vivax: the first case in Brazil. Trans R Soc Trop Med Hyg 86: 128.
43. Harinasuta T, Suntharasamai P, Viravan C 1965. Chloroquine-resistant falciparum malaria in Thailand. Lancet 2: 657-660.
44. Jambou R, Legrand E, Niang M, Khim N, Lim P, Volney B, Ekala M, Bouchier C, Esterre P, Fandeur T, Mercereau-Puijalon O 2005. Resistance of Plasmodium falciparum field isolates to in vitro artemether and point mutations of the SERCA-type PfATPase6. Lancet 366: 1960-1963.
45. Kremsner PG, Zotter GM, Feldmeier H, Graninger W, Kollaritsch M, Wiedermann G, Rocha RM, Wernsdorfer WH 1989. In vitro drug sensitivity of Plasmodium falciparum in Acre, Brazil. Bull World Health Organ 67: 289-293.
46. Kremsner PG, Zotter GM, Grainger W, Feldmeier H 1987. Amodiaquine-resistant malaria in Brazil. Lancet 2: 684.
47. Krudsood S, Tangpukdee N, Wilairatana P, Phophak N, Baird JK, Brittenham GM, Looareesuwan S 2008. High-dose primaquine regimens against relapse of Plasmodium vivax malaria. Am J Trop Med Hyg 78: 736-740.
48. Kublin JG, Cortese JF, Njunju EM, Mukadam RA, Wirima JJ, Kazembe PN, Djimdé AA, Kouriba B, Taylor TE, Plowe CV 2003. Reemergence of chloroquine-sensitive Plasmodium falciparum malaria after cessation of chloroquine use in Malawi. J Infect Dis 187: 1870-1875.
49. Lacerda MVG, Zackiewicz C, Alecrim WD, Alecrim MGC 2007. The neglected Plasmodium vivax: are researchers from endemic areas really concerned about new treatment options? Rev Soc Bras Med Trop 40: 489-490.
50. Ladislau JLB 2008. Status da implementação de ACT no Brasil [homepage on the Internet], Rio de Janeiro. Available from: actwithasmq.org/pdf/Ladislau_MS.pdf.
51. Loiola C, Mangabeira da Silva C, Tauil P 2002. Controle da malária no Brasil: 1965 a 2001. Rev Panam Salud Publica 11: 235-244.
52. Loyola EG, Rodriguez MH 1992. Chloroquine-resistant Plasmodium vivax in Brazil. Trans R Soc Trop Med Hyg 86: 570-571.
53. Menezes C, Kirchgatter K, Di Santi S, Paula G, Ferreira E 2001. In vitro evaluation of quinidine sensitivity in Brazilian Plasmodium falciparum isolates: comparative analysis to quinine and chloroquine. Rev Inst Med Trop Sao Paulo 43: 221-226.
54. Mita T, Kaneko A, Lum JK, Bwijo B, Takechi M, Zungu IL, Tsukahara T, Tanabe K, Kobayakawa T, Björkman A 2003. Recovery of chloroquine sensitivity and low prevalence of the Plasmodium falciparum chloroquine resistance transporter gene mutation K76T following the discontinuance of chloroquine use in Malawi. Am J Trop Med Hyg 68: 413-415.
55. Moore D, Lanier J 1961. Observations on two Plasmodium falciparum infections with an abnormal response to chloroquine. Am J Trop Med Hyg 10: 5-9.
56. Neifer S, Kremsner PG 1991. Drug susceptibility of Plasmodium falciparum in the western Amazon region, state of Acre, Brazil. Rev Inst Med Trop Sao Paulo 33: 205-211.
57. Neiva A 1910. Formação de raça do hematozoário do impaludismo rezistente à quinina. Mem Inst Oswaldo Cruz 2: 131-140.
58. Noedl H, Se Y, Schaecher K, Smith B, Socheat D, Fukuda M 2008. Evidence of artemisinin-resistant malaria in western Cambodia. N Engl J Med 359: 2619-2620.
59. Nomura T, Carlton JM, Baird JK, del Portillo HA, Fryauff DJ, Rathore D, Fidock DA, Su X, Collins WE, McCutchan TF, Wootton JC, Wellems TE 2001. Evidence for different mechanisms of chloroquine resistance in 2 Plasmodium species that cause human malaria. J Infect Dis 183: 1653-1661.
60. Noronha E, Alecrim MG, Romero GA, Macêdo V 2000. RIII mefloquine resistance in children with falciparum malaria in Manaus, AM, Brazil. Rev Soc Bras Med Trop 33: 201-205.
61. Oliveira-Ferreira J, Lacerda MV, Brasil P, Ladislau JL, Tauil PL, Daniel-Ribeiro CT 2010. Malaria in Brazil: an overview. Malaria J 9: 115.
62. Orjuela-Sánchez P, da Silva NS, da Silva-Nunes M, Ferreira MU 2009a. Recurrent parasitemias and population dynamics of Plasmodium vivax polymorphisms in rural Amazonia. Am J Trop Med Hyg 81: 961-968.
63. Orjuela-Sánchez P, de Santana Filho FS, Machado-Lima A, Chehuan YF, Costa MR, Alecrim MG, del Portillo HA 2009b. Analysis of single-nucleotide polymorphisms in the crt-o and mdr1 genes of Plasmodium vivax among chloroquine-resistant isolates from the Brazilian Amazon region. Antimicrob Agents Chemother 53: 3561-3564.
64. PAHO - Pan American Health Organization 2006. RAVREDA: workshop on Measuring Antimalarial Serum Levels [homepage on the Internet], Belém. Available from: paho.org/English/AD/DPC/CD/ravreda-ami-areas.htm.
65. PAHO - Pan American Health Organization 2007. RAVREDA-AMI: Amazon Network for the Surveillance of Antimalarial Drug Resistance/Amazon Malaria Initiative [homepage on the Internet]. Available from: paho.org/English/AD/DPC/CD/ravreda-ami.htm.
66. PAHO - Pan American Health Organization 2008. Report on situation of malaria in the Americas. Regional chapter. [home-page on the Internet]. Available from: new.paho.org/hq/index.php?option=com_content&task=view&id=2459&Itemid=2000.
67. Passos AD, Osanai CH, Reyes S 1987. In vivo resistance of Plasmodium falciparum to 4-aminoquinolines and to a sulfadoxine-pyrimethamine combination. II - The Emperatriz study, Maranhão, 1983-1984. Rev Soc Bras Med Trop 20: 109-113.
68. Peterson DS, Di Santi SM, Povoa M, Calvosa VS, Do Rosario VE, Wellems TE 1991. Prevalence of the dihydrofolate reductase Asn-108 mutation as the basis for pyrimethamine-resistant falciparum malaria in the Brazilian Amazon. Am J Trop Med Hyg 45: 492-497.
69. Peterson DS, Walliker D, Wellems TE 1988. Evidence that a point mutation in dihydrofolate reductase-thymidylate synthase confers resistance to pyrimethamine in falciparum malaria. Proc Natl Acad Sci USA 85: 9114-9118.
70. Póvoa M, Adagu I, Oliveira S, Machado R, Miles M, Warhurst D 1998. Pfmdr1 Asn1042Asp and Asp1246Tyr polymorphisms, thought to be associated with chloroquine resistance, are present in chloroquine-resistant and sensitive Brazilian field isolates of Plasmodium falciparum. Exp Parasitol 88: 64-68.
71. Pukrittayakamee S, Vanijanonta S, Chantra A, Clemens R, White NJ 1994. Blood stage antimalarial efficacy of primaquine in Plasmodium vivax malaria. J Infect Dis 169: 932-935.
72. Ramos Junior WM, Sardinha JF, Costa MR, Santana MS, Alecrim MG, Lacerda MV 2010. Clinical aspects of hemolysis in patients with P. vivax malaria treated with primaquine, in the Brazilian Amazon. Braz J Infect Dis 14: 410-412.
73. Reyes S 1981. Malarial infections caused by Plasmodium falciparum resistant to chloroquine treatment. The situation in Brazil (1960-1981). Rev Bras Malariol Doencas Trop 33: 109-130.
74. Reyes S, Osanai CH, Passos AD 1986. In vivo resistance of Plasmodium falciparum to 4-aminoquinolines and to a sulfadoxine-pyrimethamine combination. II. Study of Manaus, Amazonas 1983-1984. Rev Bras Malariol Doencas Trop 38: 37-44.
75. Ruebush TK, Zegarra J, Cairo J, Andersen EM, Green M, Pillai DR, Marquiño W, Huilca M, Arévalo E, Garcia C, Solary L, Kain KC 2003. Chloroquine-resistant Plasmodium vivax malaria in Peru. Am J Trop Med Hyg 69: 548-552.
76. Sá JM, Nomura T, Neves J, Baird JK, Wellems TE, del Portillo HA 2005. Plasmodium vivax: allele variants of the mdr1 gene do not associate with chloroquine resistance among isolates from Brazil, Papua, and monkey-adapted strains. Exp Parasitol 109: 256-259.
77. Santana Filho F, Arcanjo A, Cheuan Y, Costa M, Martinez-Espinosa F, Vieira J, Barbosa M, Alecrim W, MG A 2007. Chloroquine-resistant Plasmodium vivax, Brazilian Amazon. Emerg Infect Dis 13: 1125-1126.
78. Santana MS, Lacerda MVG, Barbosa MGV, Alecrim WD, Alecrim MGC 2009. Glucose-6-phosphate dehydrogenase deficiency in an endemic area for malaria in Manaus: a cross-sectional survey in the Brazilian Amazon. PLoS ONE 4: e5259.
79. Segurado AA, di Santi SM, Shiroma M 1997. In vivo and in vitro Plasmodium falciparum resistance to chloroquine, amodiaquine and quinine in the Brazilian Amazon. Rev Inst Med Trop Sao Paulo 39: 85-90.
80. Shekalaghe S, Drakeley C, Gosling R, Ndaro A, van Meegeren M, Enevold A, Alifrangis M, Mosha F, Sauerwein R, Bousema T 2007. Primaquine clears submicroscopic Plasmodium falciparum gametocytes that persist after treatment with sulphadoxine-pyrimethamine and artesunate. PLoS ONE 2: e1023.
81. Silva J 1961. Terçã maligna cloroquino-resistente - uma séria ameaça ao Hinterland brasileiro. Tribuna Medica 160: 2-6.
82. Silva JR, Lopes PF 1964. Chloroquine resistance in Plasmodium falciparum in Brazil. Rev Bras Malariol Doencas Trop 16: 301-310.
83. Smithuis F, Kyaw MK, Phe O, Win T, Aung PP, Oo AP, Naing AL, Nyo MY, Myint NZ, Imwong M, Ashley E, Lee SJ, White NJ 2010. Effectiveness of five artemisinin combination regimens with or without primaquine in uncomplicated falciparum malaria: an open-label randomised trial. Lancet Infect Dis 10: 673-681.
84. Soto J, Toledo J, Gutierrez P, Luzz M, Llinas N, Cedeño N, Dunne M, Berman J 2001. Plasmodium vivax clinically resistant to chloroquine in Colombia. Am J Trop Med Hyg 65: 90-93.
85. Souza JM 1983. A phase II clinical trial of mefloquine in Brazilian male subjects. Bull World Health Organ 61: 815-820.
86. Souza JM 1986. Mefloquine clinical trials - therapeutical experience with mefloquine alone and combination (MSP) in Brazilian male subjects with falciparum malaria. Mem Inst Oswaldo Cruz 81 (Suppl. II): 259-268.
87. Souza JM 1992. Epidemiological distribution of Plasmodium falciparum drug resistance in Brazil and its relevance to the treatment and control of malaria. Mem Inst Oswaldo Cruz 87 (Suppl. III): 343-348.
88. Souza JM, Sheth UK, de Oliveira RM, Roulet H, de Souza SD 1985. An open, randomized, phase III clinical trial of mefloquine and of quinine plus sulfadoxine-pyrimethamine in the treatment of symptomatic falciparum malaria in Brazil. Bull World Health Organ 63: 603-609.
89. Tjitra E, Anstey NM, Sugiarto P, Warikar N, Kenangalem E, Karyana M, Lampah DA, Price RN 2008. Multidrug-resistant Plasmodium vivax associated with severe and fatal malaria: a prospective study in Papua, Indonesia. PLoS Medicine 5: e128.
90. Vasconcelos KF, Plowe CV, Fontes CJ, Kyle D, Wirth DF, Pereira da Silva LH, Zalis MG 2000. Mutations in Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase of isolates from the Amazon region of Brazil. Mem Inst Oswaldo Cruz 95: 721-728.
91. Vieira PP, das Graças Alecrim M, da Silva LH, González-Jiménez I, Zalis MG 2001. Analysis of the PfCRT K76T mutation in Plasmodium falciparum isolates from the Amazon region of Brazil. J Infect Dis 183: 1832-1833.
92. Vieira PP, Ferreira MU, Alecrim MG, Alecrim WD, da Silva LH, Sihuincha MM, Joy DA, Mu J, Su XZ, Zalis MG 2004. pfcrt polymorphism and the spread of chloroquine resistance in Plasmodium falciparum populations across the Amazon Basin. J Infect Dis 190: 417-424.
93. Walker A, Lopez-Antunano F 1968. Response to drugs of South American strains of Plasmodium falciparum. Trans R Soc Trop Med Hyg 62: 654-667.
94. Wang X, Mu J, Li G, Chen P, Guo X, Fu L, Chen L, Su X, Wellems TE 2005. Decreased prevalence of the Plasmodium falciparum chloroquine resistance transporter 76T marker associated with cessation of chloroquine use against P. falciparum malaria in Hainan, People's Republic of China. Am J Trop Med Hyg 72: 410-414.
95. Wells TN, Burrows JN, Baird JK 2010. Targeting the hypnozoite reservoir of Plasmodium vivax: the hidden obstacle to malaria elimination. Trends Parasitol 26: 145-151.
96. WHO - World Health Organization 2010. World Malaria Report 2010 [homepage on the internet]. Available from: who.int/malaria/world_malaria_report_2010/en/index.html.
97. Young M, Moore D 1961. Chloroquine resistance in Plasmodium falciparum. Am J Trop Med Hyg 10: 317-320.
98. Zalis M, Pang L, Silveira M, Milhous W, Wirth D 1998. Characterization of Plasmodium falciparum isolated from the Amazon region of Brazil: evidence for quinine resistance. Am J Trop Med Hyg 58: 630-637.
99. Zhou Z, Griffing SM, de Oliveira AM, McCollum AM, Quezada WM, Arrospide N, Escalante AA, Udhayakumar V 2008. Decline in sulfadoxine-pyrimethamine-resistant alleles after change in drug policy in the Amazon region of Peru. Antimicrob Agents Chemother 52: 739-741.
100. Zolg JW, Plitt JR, Chen GX, Palmer S 1989. Point mutations in the dihydrofolate reductase-thymidylate synthase gene as the molecular basis for pyrimethamine resistance in Plasmodium falciparum. Mol Biochem Parasitol 36: 253-262.